Thank you for using rssforward.com! This service has been made possible by all our customers. In order to provide a sustainable, best of the breed RSS to Email experience, we've chosen to keep this as a paid subscription service. If you are satisfied with your free trial, please sign-up today. Subscriptions without a plan would soon be removed. Thank you!
A new Canadian study shows that operating without interrupting warfarin treatment at the time of cardiac device surgery is safe and markedly reduces the incidence of clinically significant hematomas compared to the current standard of care. The new findings were released at Heart Rhythm 2013, the Heart Rhythm Society's 34th Annual Scientific Sessions, and are published online in The New England Journal of Medicine (NEJM). At least a quarter of patients that require pacemaker or implantable defibrillator surgery are taking warfarin to reduce the risk of a stroke...
13 May, 2013
-
Source: http://www.medicalnewstoday.com/releases/260372.php
--
Manage subscription | Powered by rssforward.com
Post a Comment